• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth - Product Image

OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth

  • ID: 2358422
  • November 2012
  • 104 Pages
  • GBI Research

OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth

Summary

GBI Research, the leading business intelligence provider, has released its latest research, “OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth”, which provides insights into the up-and-coming trends of the Over the Counter (OTC) pharmaceutical market by analyzing the trends in population health, healthcare and self-care in seven emerging markets: China, India, Russia, Brazil, Mexico, Indonesia and Turkey.

Six main product categories are covered in the report -

- Cough, cold and allergy treatments
- Analgesics and antipyretics
- Gastrointestinal remedies
- Dermatological products
- Vitamins, minerals and supplements
- Lifestyle OTC products

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

All seven markets are expected READ MORE >

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction

3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview
3.1 Overview
3.2 OTC Pharmaceuticals
3.3 Rx-to-OTC Switching
3.4 Regulation of OTC Pharmaceuticals
3.4.1 China
3.4.2 India
3.4.3 Russia
3.4.4 Brazil
3.4.5 Mexico
3.4.6 Turkey
3.4.7 Indonesia

4 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Product Types
4.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview
4.2 Leading Product Types
4.2.1 Cough, Cold and Allergy
4.2.2 Analgesics/Antipyretics
4.2.3 Gastrointestinal
4.2.4 Dermatologicals
4.2.5 Vitamins, Minerals and Supplements
4.2.6 Lifestyle OTC Products

5 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Comparison
5.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, 2011-2018
5.2 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Market Drivers and Restraints
5.3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, Forecast Methodology

6 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Geographical Breakdown
6.1 China
6.1.1 Introduction
6.1.2 OTC Category Analysis
6.1.3 Key Growth Drivers and Restraints
6.1.4 OTC Sales Forecast to 2018
6.1.5 Recent Developments
6.1.6 Outlook
6.2 India
6.2.1 Introduction
6.2.2 OTC Category Analysis
6.2.3 Key Growth Drivers and Restraints
6.2.4 OTC Sales Forecast to 2018
6.2.5 Recent Developments
6.2.6 Outlook
6.3 Russia
6.3.1 Introduction
6.3.2 OTC Category Analysis
6.3.3 Key Growth Drivers and Restraints
6.3.4 OTC Sales Forecast to 2018
6.3.5 Recent Developments
6.3.6 Outlook
6.4 Brazil
6.4.1 Introduction
6.4.2 OTC Category Analysis
6.4.3 Key Growth Drivers and Restraints
6.4.4 OTC Sales Forecast to 2018
6.4.5 Recent Developments
6.4.6 Outlook
6.5 Mexico
6.5.1 Introduction
6.5.2 OTC Category Analysis
6.5.3 Key Growth Drivers and Restraints
6.5.4 OTC Sales Forecast to 2018
6.5.5 Recent Developments
6.5.6 Outlook
6.6 Turkey
6.6.1 Introduction
6.6.2 OTC Category Analysis
6.6.3 Key Growth Drivers and Restraints
6.6.4 OTC Sales Forecast to 2018
6.6.5 Recent Developments
6.6.6 Outlook
6.7 Indonesia
6.7.1 Introduction
6.7.2 OTC Category Analysis
6.7.3 Key Growth Drivers and Restraints
6.7.4 OTC Sales Forecast to 2018
6.7.5 Recent Developments
6.7.6 Outlook

7 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Takeaway

8 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Appendix
8.1 Abbreviations
8.2 Sources
8.3 Research Methodology
8.3.1 Coverage
8.3.2 Secondary Research
8.3.3 Primary Research
8.3.4 Therapeutic Landscape
8.3.5 Expert Panel Validation
8.4 Contact Us
8.5 Disclaimer

1.1 List of Tables

Table 1: OTC Market, Seven Emerging Markets, Sales ($bn), 2011-2018
Table 2: OTC Market, Seven Emerging Markets, Drivers and Restraints
Table 3: OTC Market, Drivers and Restraints, China
Table 4: OTC Market, China, Sales ($bn), 2011-2018
Table 5: OTC Market, Drivers and Restraints, India
Table 6: OTC Market, India, Sales ($bn), 2011-2018
Table 7: OTC Market, Drivers and Restraints, Russia
Table 8: OTC Market, Russia, Sales ($bn), 2011-2018
Table 9: OTC Market, Drivers and Restraints, Brazil
Table 10: OTC Market, Brazil, Sales ($bn), 2011-2018
Table 11: OTC Market, Drivers and Restraints, Mexico
Table 12: OTC Market, Mexico, Sales ($bn), 2011-2018
Table 13: OTC Market, Drivers and Restraints, Turkey
Table 14: OTC Market, Turkey, Sales ($bn), 2011-2018
Table 15: OTC Market, Drivers and Restraints, Indonesia
Table 16: OTC Market, Indonesia, Sales ($bn), 2011-2018

1.2 List of Figures

Figure 1: OTC Market, Seven Emerging Markets, Sales by Markets ($bn), 2011-2018
Figure 2: OTC Market, Seven Emerging Markets, Annual Growth Rates (%), 2011-2018
Figure 3: Population Pyramid by Age Class, China, 2010
Figure 4: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 5: Main Causes of Death, China, Ages 0-14, Both Sexes (%), 2008
Figure 6: Main Causes of Death, China, Ages 15-59, Both Sexes (%), 2008
Figure 7: Main Causes of Death, China, Ages >60, Both Sexes (%), 2008
Figure 8: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 9: OTC Market, China, by Category (Including TCM), Sales (%), 2011
Figure 10: OTC Market, China, by Category (Excluding TCM), Sales (%), 2011
Figure 11: OTC Market, China, Sales ($bn), 2011-2018
Figure 12: Population Pyramid, India, 2010
Figure 13: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 14: Main Causes of Death, India, Ages 0-14, Both Sexes (%), 2008
Figure 15: Main Causes of Death, India, Ages 15-59, Both Sexes (%), 2008
Figure 16: Main Causes of Death, India, Ages >60, Both Sexes (%), 2008
Figure 17: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 18: OTC Market, India, by Category, Sales (%),2011
Figure 19: OTC Market, India, Sales ($bn), 2011-2018
Figure 20: Population Pyramid, Russia, 2010
Figure 21: Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 22: Main Causes of Death, Russia, Ages 0-14, Both Sexes (%), 2008
Figure 23: Main Causes of Death, Russia, Ages 15-59, Both Sexes (%), 2008
Figure 24: Main Causes of Death, Russia, Age >60, Both Sexes (%), 2008
Figure 25: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 26: OTC Market, Russia, by Category, Sales (%), 2011
Figure 27: OTC Market, Russia, Sales ($bn), 2011-2018
Figure 28: Population Pyramid, Brazil, 2010
Figure 29: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 30: Main Causes of Death, Brazil, Ages 0-14, Both Sexes (%), 2008
Figure 31: Main Causes of Death, Brazil, Ages 15-59, Both Sexes (%), 2008
Figure 32: Main Causes of Death, Brazil, Ages >60, Both Sexes (%), 2008
Figure 33: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 34: OTC Market, Brazil, by Category, Sales (%), 2011
Figure 35: OTC Market, Brazil, Sales ($bn), 2011-2018
Figure 36: Population Pyramid, Mexico, 2010
Figure 37: Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 38: Main Causes of Death, Mexico, Ages 0-14, Both Sexes (%), 2008
Figure 39: Main Causes of Death, Mexico, Ages 15-59, Both Sexes (%), 2008
Figure 40: Main Causes of Death, Mexico, Ages >60, Both Sexes (%), 2008
Figure 41: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 42: OTC Market, Mexico, by Category, Sales (%), 2011
Figure 43: OTC Market, Mexico, Sales ($bn), 2011-2018
Figure 44: Population Pyramid, Turkey, 2010
Figure 45: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 46: Main Causes of Death, Turkey, Ages 0-14, Both Sexes (%), 2008
Figure 47: Main Causes of Death, Turkey, Ages 15-59, Both Sexes (%), 2008
Figure 48: Main Causes of Death, Turkey, Ages >60, Both Sexes (%), 2008
Figure 49: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 50: OTC Market, Turkey, by Category, Sales (%), 2011
Figure 51: OTC Market, Turkey, Sales ($bn), 2011-2018
Figure 52: Population Pyramid, Indonesia, 2010
Figure 53: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 54: Main Causes of Death, Indonesia, Ages 0-14, Both Sexes (%), 2008
Figure 55: Main Causes of Death, Indonesia, Ages 15-59, Both Sexes (%), 2008
Figure 56: Main Causes of Death, Indonesia, Ages >60, Both Sexes (%), 2008
Figure 57: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 58: OTC Market, Indonesia, by Category (Including TCM), Sales (%), 2011
Figure 59: OTC Market, Indonesia, by Category (Excluding TCM), Sales (%), 2011
Figure 60: OTC Market, Indonesia, Sales ($bn), 2011-2018
Figure 61: GBI Research Market Forecasting Model

Russia’s Rapidly Expanding Self-medication Market

A growing elderly population, rising obesity and a huge number of smokers are key contributors to a surging Over-The-Counter (OTC) drugs market in Russia, states a new report from healthcare industry analysts GBI Research.

The firm’s latest publication* predicts the country’s OTC market to climb in value from last year’s total of US$7.1 billion to US$16 billion by just 2018, at an impressive Compound Annual Growth Rate of 12.4% – the highest of any of the seven emerging markets investigated.

According to GBI Research, the lifestyle OTC medications sector is a significant contributor to the industry, accounting for 19% of the total last year, and is expected become the number one OTC market contributor in the future as more Russian’s seek to address unhealthy habits.

The Eastern European nation is home to the largest percentage of smokers in the world and has a growing problem with obesity, but a strong lifestyle OTC industry indicates a healthy cultural desire to combat these issues.

The cough, cold and allergy category also holds a large market share at 18%. Since the fall of the Soviet Union, tuberculosis has been on the rise, and while this is a serious condition that requires medical attention and prescription drugs, it is likely that OTC products will be used alongside professional treatments to help ease disease symptoms.

Despite having a far greater population, China’s OTC market value is expected to be only marginally greater than Russia’s in 2018, at US$16.6 billion. Of the seven emerging markets identified in GBI Research’s report, Brazil is predicted to have the third biggest OTC market value at US$8.3 billion, while India is placed fourth at US$5.2 billion.

* OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth

This report provides insights into the up-and-coming trends of the Over the Counter (OTC) pharmaceutical market by analyzing the trends in population health, healthcare and self-care in seven emerging markets: China, India, Russia, Brazil, Mexico, Indonesia and Turkey.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GBI Research’s team of industry experts.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos